Live Markets
Tuesday, July 28, 2026·George Town, KY·29°·Partly Cloudy
Markets Open · NYSE·Newsletter·Masthead·
VOL. XII · NO. 117Established MMXIV · George Town, Grand CaymanAtlantic Edition · $4.50

The Cayman Journal

Finance · Business · Technology · Caribbean & Global Affairs
Markets · Healthcare

Anbio Biotechnology (NNNN)

NGM · Medical Instruments & Supplies

$10.15-0.03 (-0.29%)Quote refreshed

Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires

Market Cap
$445.5M
P/E (TTM)
67.67
EPS
$0.15
Div Yield
52W Range
$8.30–$54.95
Beta

Company overview

Anbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, and internationally. The company offers lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification, SHA dry chemistry, chemiluminescence immunoassay, and real-time polymerase chain reaction solutions; and SARS-CoV-2 and SARS-CoV-2/Flu A/Flu B antigen rapid test kits. It serves over-the-counter, point-of-care testing, and laboratory markets. Anbio Biotechnology was incorporated in 2021 and is based in Frankfurt am Main, Germany.

Peers in Medical Instruments & Supplies

All in industry →

Recent press releases

Anbio Biotechnology has not issued a press release in this window.

SEC filings

All filings →

Anbio Biotechnology has not filed an SEC document in this window.

Anbio Biotechnology has no reported insider trades in the last 90 days.

Institutional holders

All holders →
As of 2025-12-31 · prior 2025-09-30
28 sh-99.7%
25,763 sh0.0%
1,000 sh-58.7%
2,849 sh+196.8%
100 sh0.0%

People at Anbio Biotechnology

All people →

No officers or directors have been indexed for Anbio Biotechnology.

Quarterly financials

Full financials →
Revenue trend
12/24
$8.2M
NI $2.4M
RevenueNI = Net Income
EPS trend (diluted)
EPS history not available.
Anbio Biotechnology (NNNN) Stock Quote, Press... | Cayman Journal | Cayman Journal